Research articles
ScienceAsia 52 (2026):ID 2026069 1-9 |doi:
10.2306/scienceasia1513-1874..069
Gut microbial composition and metabolites influence serum
IgA homeostasis
Xiaobo Zhanga, Han Xiaoa, Yan Wanga, Zhifeng Panb, Guangshu Haob,?
ABSTRACT: Immunoglobulin A (IgA) is a key regulator of gut microbiota homeostasis, shaping both microbial
community composition and metabolic output to maintain host-microbe symbiosis. However, the detailed mechanisms
underlying how IgA modulates microbial diversity and coordinates the production of metabolites critical for immune
and metabolic fitness remain poorly investigated. We combined clinical sampling, murine models, and multi-omics
analyses to dissect these interactions. Specifically, fresh fecal samples were collected from adult volunteers and analyzed
for gut microbiota diversity using 16S rDNA sequencing, while serum IgA concentrations were measured via ELISA.
Subsequently, a high-IgA (HIgA) mouse model was established to validate the association between Prevotella and serum
IgA level, which confirmed that metabolites derived from Prevotella, rather than viable bacteria or culture medium
components, dominantly reduce serum IgA concentrations. Furthermore, metabolomics and proteomics analysis
identified critical metabolites influencing IgA expression. Gut microbiota diversity was significantly reduced in the HIgA
group, with a robust inverse correlation between Prevotella abundance and serum IgA levels. Metabolomic analysis
further identified 596 differentially expressed microbial metabolites, with fatty alcohols, purines, and their derivatives
emerging as key regulators of IgA levels. Additionally, pathways related to penicillin metabolism and cholinergic
drugs, as well as the key neural signaling proteins UNC13B and CNTNAP1, were implicated in IgA modulation.
These findings highlight the strong link between gut microbiota composition and serum IgA regulation, particularly
the negative correlation with abundance of Prevotella, which suggests considerable potential for developing targeted
immunotherapies based on microbiota-driven immune modulation.
Download PDF
Downloads Views
| a |
Cuiying Biomedical Research Center, The Second Hospital & Clinical Medicine School, Lanzhou University,
Lanzhou, Gansu 730030 China |
| b |
Department of Pathology, Gansu Provincial Maternity and Chlid-Care Hospital, Lanzhou, Gansu 730050 China |
* Corresponding author, E-mail: hgs199099@126.com
Received 27 Oct 2025, Accepted 12 Jul 2026
|